Can echocardiographic screening in the early days of life detect critical congenital heart disease among apparently healthy newborns?

Abstract

BackgroundDelayed diagnosis of critical congenital heart disease (CCHD) carries a serious risk of mortality, morbidity, and handicap. As echocardiography is commonly used to diagnose congenital heart disease (CHD), echocardiographic investigations in newborns may be helpful in detecting CCHD earlier and with higher sensitivity than when using other screening methods. The present study aimed to evaluate the effectiveness of echocardiographic screening for CCHD in a tertiary care center.MethodsA retrospective chart review was conducted among newborns delivered at Hamamatsu University Hospital between June 2009 and May 2016. The study included consecutive newborns who underwent early echocardiographic screening (within the first 5 days of life) performed by pediatric cardiologists, were born at ≥36 weeks of gestation, had a birthweight ≥2300 g, and were cared for in the well-baby nursery. Newborns admitted to the neonatal intensive care unit, as well as those with prenatal diagnosis of CHD and/or clinical symptoms or signs of CHD were excluded. Four CHD outcome categories were defined: critical, serious, clinically significant, and clinically non-significant.ResultsA total of 4082 live newborns were delivered during the study period. Of 3434 newborns who met the inclusion criteria and had complete echocardiography data, 104 (3.0%) were diagnosed as having CHD. Among these, none was initially diagnosed as having critical or serious CHD. Of the 95 newborns who continued follow-up with a cardiologist, 61 (64%) were determined to have non-significant CHDs that resolved within 6 months of life. Review of excluded newborns revealed nine cases of critical or serious CHD; among these newborns, six were diagnosed prenatally and three had some clinical signs of CHD prior to hospital discharge.ConclusionsIn our tertiary care center, echocardiography screening within the first 5 days of life did not help improve CCHD detection rate in newborns without prenatal diagnosis or clinical signs of CHD. Echocardiographic screening may be associated with increased rate of false-positives (defects resulting in clinically non-significant CHDs) in newborns without prenatal diagnosis or suspicion of CHD.

Late Presentation of Partial Atrioventricular Septal Defect: A Case Report

“…Some data discuss the utility of echocardiographic screening for the general population considering it as part of clinical neonatal examination before discharge. However, a high false positive was seen in this very early age which may lead to unnecessary intervention in addition to problems regarding the cost of applying such a screening program on a wide base (12,13) . Further, a study needs to be done to assess the significance of echocardiographic screening after 6 months of age to detect asymptomatic lesions that need early repair.…”

Determining the incidence of heart malformations in neonates: A novel and clinically approved solution

“…It must be performed by a pediatric cardiologist for the patient's management; however, the diagnostic time is relatively long. Consequently, performing a Doppler ultrasound examination for every neonate is impractical; therefore, diagnosing all neonates for detecting congenital heart malformations remains debatable ( 5 , 16 , 17 ).…”

Ascertaining the Prevalence of Heart Malformations in Neonates: A Novel Clinically Approved Solution

“…Doppler echocardiography is an accurate screening modality; however, it requires intervention by a pediatric cardiologist, and diagnostic timing is relatively long. In addition, performing Doppler ultrasound screening for every neonate is not practical, and it remains a subject of debate in as much as screening all neonates for congenital heart malformations is concerned (5,16,17).…”